Company Filing History:
Years Active: 2024-2025
Title: Kerstin Jahn-Hofmann: Innovator in RNA Therapeutics
Introduction
Kerstin Jahn-Hofmann is a prominent inventor based in Frankfurt-am-Main, Germany. She has made significant contributions to the field of RNA therapeutics, holding 2 patents that focus on innovative methods for gene expression modulation.
Latest Patents
Her latest patents include "RNA compositions and methods for inhibiting ANGPTL8," which relates to double-stranded RNAs (dsRNAs) targeting ANGPTL8. This invention outlines methods for inhibiting ANGPTL8 gene expression and treating conditions associated with it. Another notable patent is "Nucleotide precursors, nucleotide analogs and oligomeric compounds containing the same." This patent discusses novel nucleotide precursors and analogs that can be incorporated into oligonucleotides, enhancing their biological activity, stability, and potency.
Career Highlights
Kerstin is currently employed at Sanofi, where she continues to advance her research in RNA-based therapies. Her work has the potential to significantly impact the treatment of various genetic conditions.
Collaborations
She collaborates with esteemed colleagues, including Armin Hofmeister and Bodo Brunner, to further her research and development efforts in the field.
Conclusion
Kerstin Jahn-Hofmann is a trailblazer in RNA therapeutics, with her innovative patents paving the way for new treatment methodologies. Her contributions to the field are invaluable and continue to inspire future research.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.